Chemoprevention of oesophageal cancer and the AspECT trial. | Recent Results Cancer Res;181: 161-9, 2009. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Chemoprevention of oesophageal cancer and the AspECT trial.

Das, Debasish; Chilton, Andrew P; Jankowski, Janusz A.

Affiliation

Das D; Digestive Disease Centre, Leicester Royal Infirmary, UK.

Recent Results Cancer Res ; 181: 161-9, 2009.

Article in En | MEDLINE | ID: mdl-19213566

Subject(s)

Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Anti-Ulcer Agents/therapeutic use; Aspirin/therapeutic use; Esomeprazole/therapeutic use; Esophageal Neoplasms/prevention & control; Clinical Trials as Topic; Humans

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Anti-Inflammatory Agents, Non-Steroidal / Aspirin / Esomeprazole / Anti-Ulcer Agents Type of study: Clinical_trials Limits: Humans Language: En Journal: Recent Results Cancer Res Year: 2009 Document type: Article Affiliation country: United kingdom

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Anti-Inflammatory Agents, Non-Steroidal / Aspirin / Esomeprazole / Anti-Ulcer Agents Type of study: Clinical_trials Limits: Humans Language: En Journal: Recent Results Cancer Res Year: 2009 Document type: Article Affiliation country: United kingdom